Late mortality and determinants in patients with heart failure and preserved systolic left ventricular function: The Israel nationwide heart failure survey

Israel Medical Association Journal

Volumn 9, Issue 4, 2007, Pages 234-238

  Lewis, Basil S ^a   Shotan, Avraham ^b   Gottlieb, Shmuel ^c   Behar, Shlomo ^d   Halon, David A ^a   Boyko, Valentina ^d   Leor, Jonathan ^d   Grossman, Ehud ^d   Zimlichman, Reuven ^e   Porath, Avi ^f   Mittelman, Moshe ^g   Caspi, Abraham ^h   Garty, Moshe ^g  

^a CARMEL MEDICAL CENTER   (Israel)

^b HILLEL YAFFE MEDICAL CENTER   (Israel)

^c BIKUR CHOLIM HOSPITAL   (Israel)

^d SHEBA MEDICAL CENTER   (Israel)

^e WOLFSON MEDICAL CENTER   (Israel)

^f BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^g RABIN MEDICAL CENTER   (Israel)

^h KAPLAN MEDICAL CENTER   (Israel)

Author keywords

Diastolic dysfunction; Hearth failure; Mortality; Pharmacotherapy

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTICOAGULANT AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; WARFARIN;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CARDIOLOGY; CLINICAL FEATURE; COMORBIDITY; ECHOCARDIOGRAPHY; EVIDENCE BASED PRACTICE; FEMALE; HEALTH SURVEY; HEART ATRIUM FIBRILLATION; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FUNCTION; HOSPITAL ADMISSION; HUMAN; INTERNAL MEDICINE; ISRAEL; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; POPULATION RESEARCH; PREVALENCE; PUBLIC HOSPITAL; SEX RATIO; SYSTOLE; TREATMENT OUTCOME;

AGED; ECHOCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HEART FAILURE, CONGESTIVE; HUMANS; INPATIENTS; ISRAEL; MALE; MYOCARDIAL CONTRACTION; POPULATION SURVEILLANCE; PROSPECTIVE STUDIES; SEX DISTRIBUTION; SURVIVAL RATE; SYSTOLE; TIME FACTORS; VENTRICULAR FUNCTION, LEFT;

EID: 34247897169     PISSN: 15651088     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Petrie M, McMurray J. Changes in notions about heart failure. Lancet 2001;358:432-4.
2. Vasan RS, Benjamin EJ. Diastolic heart failure - no time to relax. N Engl J Med 2001;344:56-9.
3. Yancy CW, Lopatin M, Stevenson LW, De Marco T, Fonarow GC. Clinical presentation, management, and in-hospital outcomes of patients admitted with acute decompensated heart failure with preserved systolic function: a report from the Acute Decompensated Heart Failure National Registry (ADHERE) Database. J Am Coll Cardiol 2006;47:76-84.
4. Kitzman DW, Little WC, Brubaker PH, et al. Pathophysiological characterization of isolated diastolic heart failure in comparison to systolic heart failure. JAMA 2002;288:2144-50.
5. Lenzen MJ, Scholte op Reimer WJ, Boersma E, et al. Differences between patients with a preserved and a depressed left ventricular function: a report from the EuroHeart Failure Survey. Eur Heart J 2004;25:1214-20.
6. Shibata MC, Flather MD, Bohm M, et al. Study of the Effects of Nebivolol Intervention on Outcomes and Rehospitalisation in Seniors with Heart Failure (SENIORS). Rationale and design. Int J Cardiol 2002;86:77-85.
7. Yusuf S, Pfeffer MA, Swedberg K, et al. Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial. Lancet 2003;362:777-81.
8. Gottdiener JS, McClelland RL, Marshall R, et al. Outcome of congestive heart failure in elderly persons. influence of left ventricular systolic function. The Cardiovascular Health Study. Ann Intern Med 2002;137:631-9.
9. Owan TE, Hodge DO, Herges RM, Jacobsen SJ, Roger VL, Redfield MM. Trends in prevalence and outcome of heart failure with preserved ejection fraction. N Engl J Med 2006;355:251-9.
10. Fonarow GC. The Acute Decompensated Heart Failure National Registry (ADHERE): opportunities to improve care of patients hospitalized with acute decompensated heart failure. Rev Cardiovasc Med 2003;4(Suppl 7):S21-30.
11. Varadarajan P, Pai RG. Prognosis of congestive heart failure in patients with normal versus reduced ejection fractions: results from a cohort of 2,258 hospitalized patients, J Card Fail 2003;9:107-12.
12. Gustafsson F, Torp-Pedersen C, Brendorp B, Seibaek M, Burchardt H, Kober L. Long-term survival in patients hospitalized with congestive heart failure: relation to preserved and reduced left ventricular systolic function. Eur Heart J 2003;24:863-70.
13. Bhatia RS, Tu JV, Lee DS, et al. Outcome of heart failure with preserved ejection fraction in a population-based study. N Engl J Med 2006;355:260-9.
14. Cleland JG, Swedberg K, Follath F, et al. The EuroHeart Failure survey programme - a survey on the quality of care among patients with heart failure in Europe. Part I: Patient characteristics and diagnosis. Eur Heart J 2003;24:442-63.
15. Cohen-Solal A, Desnos M, Delahaye F, Emeriau JP, Hanania G. A national survey of heart failure in French hospitals. The Myocardiopathy and Heart Failure Working Group of the French Society of Cardiology, the National College of General Hospital Cardiologists and the French Geriatrics Society. Eur Heart J 2000;21:763-9.
16. Redfield MM, Jacobsen SJ, Burnett JC, Jr., Mahoney DW, Bailey KR, Rodeheffer RJ. Burden of systolic and diastolic ventricular dysfunction in the community: appreciating the scope of the heart failure epidemic. JAMA 2003;289:194-202.
17. Lewis BS, Gotsman MS. Current concepts of left ventricular relaxation and compliance. Am Heart J 1980;99:101-12.
18. Arbab-Zadeh A, Dijk E, Prasad A, et al. Effect of aging and physical activity on left ventricular compliance. Circulation 2004; 110:1799-805.
19. Gaasch WH, Zile MR. Left ventricular diastolic dysfunction and diastolic heart failure. Annu Rev Med 2004;55:373-94.
20. The CONSENSUS Trial Study group. Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). N Engl J Med 1987;316:1429-35.
21. Krum H, Roecker EB, Mohacsi P, et al. Effects of initiating carvedilol in patients with severe chronic heart failure: results from the COPERNICUS Study. JAMA 2003;289:712-18.
22. Philbin EF, Rocco TA, Jr., Lindenmuth NW, Ulrich K, Jenkins PL. Systolic versus diastolic heart failure in community practice: clinical features, outcomes, and the use of angiotensin-converting enzyme inhibitors. Am J Med 2000;109:605-13.
23. McMurray JJ. Angiotensin receptor blockers for chronic heart failure and acute myocardial infarction, Heart 2001;86:97-103.
24. Jones RC, Francis GS, Lauer MS. Predictors of mortality in patients with heart failure and preserved systolic function in the Digitalis Investigation Group trial, J Am Coll Cardiol 2004;44:1025-9.
25. Lewis BS, Yuval R, Pikan-Shalem R, Goldhammer E, Flugelman MY, Halon DA. Prevalence of heart failure in hospitalized patients in Israel: the Haifa experience. J Isr Heart Soc 2003;13:40-4.